Special articleEPICO 3.0. Antifungal prophylaxis in solid organ transplant recipientsEPICO 3.0. Profilaxis antifúngica en el paciente trasplantado de órgano sólido
Section snippets
1. Variables considered risk factors for the development of aspergillosis in liver transplant recipients
Answers provided by the coordinators: retransplant, the event of more than one acute rejection requiring the use of steroids or monoclonal antibodies during the first month, post-transplant renal failure, pretransplant fulminant liver failure, dialysis, poor graft function (basically primary graft failure), surgical reintervention, prior renal failure, severe bacterial infection requiring antibiotic therapy for more than 10 days, bile leak and/or primary hepaticojejustonomy, presence of
Recommendations and algorithm
Once the results achieved in the Delphi methodology regarding antifungal prophylaxis in solid organ transplant recipients were collected, five recommendations were elaborated and the conclusions are exhibited in Table 1. They are based on the questions which reached a consensus equal or higher than 70%. These recommendations and the algorithm deriving from them (Fig. 1) were validated thereafter during a face-to-face meeting with the hospital experts.
Conflict of interests
This consensus has been sponsored by MSD Laboratories, Spain.
Acknowledgements
We thank Carmen Romero and Ainhoa Torres (Entheos Editorial Group) for their excellent work and dedication to this project.
References (28)
- et al.
Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED). Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update
Enferm Infecc Microbiol Clin
(2011) - et al.
Risk factors for invasive aspergillosis in liver transplant recipients
Liver Transpl
(2002) - et al.
ESCMID Study Group for Infections in Compromised Hosts. Invasive fungal infections in solid organ transplant recipients
Clin Microbiol Infect
(2014) - et al.
Invasive fungal infection in solid organ transplant
Enferm Infecc Microbiol Clin
(2012) - et al.
Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients
Transpl Proc
(2011) - et al.
Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas–kidney transplantation
Clin Microbiol Infect
(2013) - et al.
Voriconazole prophylaxis in lung transplant recipients
Am J Transpl
(2006) - et al.
AST infectious diseases community of practice. Pneumocystis pneumonia in solid organ transplant recipients
Am J Transpl
(2009) - et al.
Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain
Am J Transpl
(2007) - et al.
Invasive aspergillosis among heart transplant recipients: a 24-year perspective
J Heart Lung Transpl
(2014)
Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis
Am J Transpl
CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain
Clin Microbiol Infect
Guidelines for the prevention of invasive mold diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Clin Microbiol Infect
Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Int J Antimicrob Agents
Cited by (0)
- ◊
All members are listed in Annex 1 COORDINATORS, Annex 2 REPRESENTATIVE EXPERTS, Annex 3 HOSPITAL EXPERTS.